← back to search

Ru Chen

Nanchang University · CN
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research focused on Renal cell carcinoma and Immune checkpoint, with related work in Odds ratio, Microglia, Surgical oncology. Notable publications include 'Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: A narrative review', 'The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis', and 'Independent Factors Affecting Postoperative Short-Term Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy'.
h-index
citations
142
works
10
NIH funding
primary concept
email

Recent publications

Integrative bioinformatics and <i>in vitro</i> exploration of EVI2A expression: unraveling its immunological and prognostic implications in kidney renal clear cell carcinoma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2024cited by 1position: lastdoi
Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone
Frontiers in Oncology 2023cited by 10position: middledoi
Delayed <scp>CO<sub>2</sub></scp> postconditioning promotes neurological recovery after cryogenic traumatic brain injury by downregulating <scp>IRF7</scp> expression
CNS Neuroscience & Therapeutics 2023cited by 10position: middledoi
Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma
BMC Cancer 2023cited by 8position: middledoi
Comprehensive analysis of the expression, prognostic value and biological importance of OVO‑like proteins in clear cell renal cell carcinoma
Oncology Letters 2023cited by 6position: middledoi
Increased Burden of Second Bladder Cancer and Rectal Cancer in Prostate Cancer Treated With Radiotherapy: Results From Surveillance, Epidemiology, and End Results
Cancer Control 2023cited by 6position: middledoi
Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: A narrative review
International Immunopharmacology 2022cited by 40position: middledoi
Bioinformatic Analysis of the Expression and Clinical Significance of the DNA Replication Regulator MCM Complex in Bladder Cancer
International Journal of General Medicine 2022cited by 8position: firstdoi
Partial Nephrectomy Versus Radical Nephrectomy for Endophytic Renal Tumors: Comparison of Operative, Functional, and Oncological Outcomes by Propensity Score Matching Analysis
Frontiers in Oncology 2022cited by 7position: middledoi
Independent Factors Affecting Postoperative Short-Term Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy
Journal of Oncology 2021cited by 25position: middledoi
The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis
Oncotarget 2017cited by 31position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Bin Fu · Nanchang University5 papers (2021–2024)Ming Jiang · Nanchang University4 papers (2022–2023)Ting Sun · Jiangxi Mental Health Center2 papers (2022–2023)Luyao Chen · Nanchang University2 papers (2021–2022)Xiangpeng Zhan · Nanchang University2 papers (2023–2024)Wen Deng · Nanchang University2 papers (2021–2022)Xiaofeng Cheng · Nanchang University2 papers (2022–2023)Bing Hu · Nanchang University2 papers (2022–2022)Guoxian Chen · Tulane University2 papers (2023–2023)Yifu Liu · Fudan University2 papers (2022–2023)Xiaoqiang Liu · Nanchang University2 papers (2021–2023)Siyuan Wang · Harbin University of Science and Technology2 papers (2022–2023)Zhicheng Zhang · Nanchang University2 papers (2022–2023)Situ Xiong · Nanchang University1 papers (2024–2024)Gongxian Wang · Nanchang University1 papers (2021–2021)Xian Jiang · Nanchang University1 papers (2021–2021)Ke Zhu · Nanchang University1 papers (2021–2021)Caihong Yang · Shanxi Medical University1 papers (2023–2023)Nan Fang · Shanxi Medical University1 papers (2023–2023)Xiaoming Zhang · Nanchang University1 papers (2023–2023)